CMF
CLBT icon

Counterpoint Mutual Funds’s Cellebrite CLBT Stock Holding History

Counterpoint Mutual Funds’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-110,211
Closed -$2.14M – 335
2025
Q1 		$2.14M Buy
110,211
+23,435
+27% +$493K 0.31% 14
2024
Q4 		$1.91M Buy
86,776
+7,569
+10% +$146K 0.24% 10
2024
Q3 		$1.33M Buy
79,207
+41,160
+108% +$611K 0.25% 11
2024
Q2 		$455K Sell
38,047
-21,254
-36% -$237K 0.11% 65
2024
Q1 		$657K Buy
+59,301
New +$605K 0.16% 30
2023
Q4 		– Sell
-17,604
Closed -$135K – 141
2023
Q3 		$135K Buy
+17,604
New +$132K 0.11% 86
2023
Q2 		– Sell
-17,970
Closed -$109K – 326
2023
Q1 		$109K Buy
+17,970
New +$97.4K 0.1% 170

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Counterpoint Mutual Funds's CLBT Position: Q2 2025 in Review

Counterpoint Mutual Funds sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 110,211 shares — an estimated $2.14M sold.

Counterpoint Mutual Funds first reported a position in CLBT in Q1 2023 and held it in 7 quarters. The position peaked at $2.14M in Q1 2025. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Counterpoint Mutual Funds reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 110,211 Cellebrite shares in Q2 2025, an estimated $2.14M.
  • Counterpoint Mutual Funds first reported a position in Cellebrite in Q1 2023 and held it in 7 quarters.
  • Counterpoint Mutual Funds's Cellebrite position peaked at $2.14M in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2025, filed 14 Jul 2025.